What You Need to Know About Sabril® (vigabatrin)

Sabril is a branded prescription medication that was approved in the U.S. in August of 2009.

Sabril is a prescription medicine used with other treatments in adults and children 10 years of age and older with refractory complex partial seizures (CPS) who have not responded well enough to several other treatments and if the possible benefits outweigh the risk of vision loss. Sabril should not be the first medicine used to treat CPS.

Sabril is a prescription medicine used in babies, 1 month to 2 years old, with infantile spasms (IS), if the possible benefits outweigh the possible risk of vision loss.

All people who take Sabril are at risk for vision loss with any amount of Sabril. The risk of vision loss may be higher the more Sabril you take daily and the longer you take it. It is not possible for your healthcare provider to know when vision loss will happen. It could happen soon after starting Sabril or any time during treatment. It may even happen after treatment has stopped.

Please see additional Important Safety Information, including Boxed Warning for risk of permanent vision loss below.

Ask for Sabril by Name

If you prefer to continue on brand-name Sabril, consult with your doctor and ask for Sabril to be specified in your prescription with the term "Dispense as Written (DAW)" or other terms required under state law. Depending on your insurance coverage, there may be differences in cost if you and your doctor choose a brand-name prescription.

Check Your Prescription

If you have been prescribed brand-name Sabril, the pharmacy may fill your prescription with a generic vigabatrin instead of the brand-name Sabril that your doctor has prescribed.

A generic version can look very similar to the brand-name medicine.

Check your medicine when you receive it to determine if you have been given brand-name Sabril as prescribed by your doctor.

Know What Branded Sabril Looks Like

This is what branded Sabril looks like

If you think you have received a generic vigabatrin instead of branded Sabril, talk to your doctor.

SABRIL® (vigabatrin) Tablets and Powder for Oral Solution

Use

SABRIL (vigabatrin) is a prescription medicine used with other treatments in adults and children 2 years of age and older with refractory complex partial seizures (CPS) who have not responded well enough to several other treatments and if the possible benefits outweigh the risk of vision loss. SABRIL should not be the first medicine used to treat CPS.

SABRIL (vigabatrin) is a prescription medicine used in babies, 1 month to 2 years old, with infantile spasms (IS), if the possible benefits outweigh the possible risk of vision loss.

IMPORTANT
SAFETY INFORMATION

EXPAND

WARNING: PERMANENT VISION LOSS

See Medication Guide and full Prescribing Information for complete information.

All people who take SABRIL:

  • You are at risk for vision loss with any amount of SABRIL.
  • Your risk of vision loss may be higher the more SABRIL you take daily and the longer you take it.
  • It is not possible for your healthcare provider to know when vision loss will happen. It could happen soon after starting SABRIL or any time during treatment. It may even happen after treatment has stopped.

IMPORTANT
SAFETY INFORMATION

COLLAPSE

WARNING: PERMANENT VISION LOSS

See Medication Guide and full Prescribing Information for complete information.

All people who take SABRIL:

  • You are at risk for vision loss with any amount of SABRIL.
  • Your risk of vision loss may be higher the more SABRIL you take daily and the longer you take it.
  • It is not possible for your healthcare provider to know when vision loss will happen. It could happen soon after starting SABRIL or any time during treatment. It may even happen after treatment has stopped.

 

 

 

For more information, please see SABRIL Medication Guidefull Prescribing Information including Boxed Warning for risk of permanent vision loss, and Instructions for Use.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The product information provided in this site is intended only for residents of the U.S. The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. Sabril may not be a fit for everyone. You and your doctor should decide if the possible benefits of taking Sabril are more important than the risk of permanent vision loss.

©2020 Lundbeck. All rights reserved. VGB-B-100004v5

Sabril is a registered trademark of Lundbeck